Comparison Overview
Catalent Pharma Solutions Limoges
Catalent Pharma Solutions Limoges
48, Rue Gilles de Roberval, Limoges, 87280, FR
Last Update: 04/02/2026
One of the very few development and manufacturing partners with the capacity and technical expertise across multiple cell types at both clinical and commercial scale. Catalent has the leadership position in the biotech industry, gene therapy offering, and delivers compr...
MENARINI Group
Via dei Sette Santi 1/3, Firenze, 50131, IT
Last Update: 02/04/2026
The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in ...
Compliance Ranges Comparison
Catalent Pharma Solutions Limoges
MENARINI Group
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Catalent Pharma Solutions Limoges in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for MENARINI Group in 2026.
Incident History - Catalent Pharma Solutions Limoges (X = Date, Y = Severity)
Catalent Pharma Solutions Limoges cyber incidents detection timeline including parent company and subsidiaries.
Incident History - MENARINI Group (X = Date, Y = Severity)
MENARINI Group cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Catalent Pharma Solutions Limoges
MENARINI Group
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.